ArticleUnited European gastroenterology journal2025

The Impact of Ustekinumab Biosimilar on Therapeutic Strategies in Crohn's Disease: A Paradigm Shift?

C Bezzio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.